HEXO在美国MKT前下跌1%，至52周低点，REVS较一年前翻了一番，但同期净亏损也大幅上升；撤回财务指导

05:59 AM EDT, 06/15/2022 (MT Newswires) -- HEXO Corp (TSX and NASDAQ: HEXO), a producer of high-quality cannabis products, overnight Tuesday said Q3 FY22 net revenues had doubled to C$45.6 million when compared to Q3'21 as the result of the accretive sales contributed by the acquisitions of Zenabis Global Inc. and Redecan (acquired Q4'21 and Q1'22, respectively). Total net loss and comprehensive loss was $146.663 million, well down from a loss of $690.254 million in the prior quarter, but well up from a loss of $20.708 million a year ago.

On withdrawal of financial guidance, the company noted that in connection with its strategic plan titled 'The Path Forward', it had previously provided guidance regarding its operational synergies and incremental increases to cash flows for the financial years ending July 31, 2022 and 2023. In light of a number of developments, circumstances and considerations, including, among others, deteriorating market and macro-economic conditions, recent changes to senior management and the pending transaction with Tilray Brands, Inc. (with potential impacts on the company's capital structure and liquidity) HEXO CFO Julius Ivancsits is embarking on a "comprehensive" review of the existing organizational and business strategy, with a continuing objective of becoming EBITDA and cash flow positive. The company now believes that it will not achieve the synergies and incremental cash flow increases to the level estimated in its previous guidance and it expects such figures and measures to be lower than previously guided. Consequently, the company announced that it is entirely withdrawing its previously issued guidance on operational synergies and expected incremental increases to cash flows for the 2022 and 2023 financial years, and said there can be no assurance that it will in the future decide to provide any guidance whatsoever with respect to any operational, financial or other measure.